Molecular mechanisms of ligand interaction with the gonadotropin- releasing hormone receptor

Endocrine Reviews

Volumn 18, Issue 2, 1997, Pages 180-205

  Sealfon, Stuart C ^a   Weinstein, Harel ^a   Millar, Robert P ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR;

AMINO ACID SEQUENCE; GENE STRUCTURE; HORMONE RECEPTOR INTERACTION; HUMAN; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0030937284     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.18.2.0295     Document Type: Review

References (239)

1. Fink G 1988 Gonadotropin secretion and its control. In: Knobil E, Neill J (eds) The Phsyiology of Reproduction. Raven Press, New York, pp 1349-1377
2. Gordon K, Hodgen GD 1992 Evolving role of gonadotropin-releasing hormone antagonists. Trends Endocrinol Metab 3:259-263
3. Barbieri RL 1992 Clinical applications of GnRH and its analogues. Trends Endocrinol Metab 3:30-34
4. Casper RF 1991 Clinical uses of gonadotropin-releasing hormone analogues. Can Med Assoc J 144:153-158
5. Conn PM, Crowley Jr WF 1991 Gonadotropin-releasing hormone and its analogues. N Engl J Med 324:93-103
6. Conn PM, Crowley Jr WF 1994 Gonadotropin-releasing hormone and its analogs. Annu Rev Med 45:391-405
7. Moghissi KS 1992 Clinical applications of gonadotropin-releasing hormones in reproductive disorders. Endocrinol Metab Clin North Am 21:125-140
8. Filicori M 1994 Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs 48:41-58
9. Emons G, Schally AV 1994 The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 9:1364-1379
10. Millar RP, King JA, Davidson JS, Milton RC 1987 Gonadotropin-releasing hormone-diversity of functions and clinical applications. S Afr Med J 72:748-755
11. Matsuo H, Baba Y, Nair RMG, Arimura A, Schally AV 1971 Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun 43:1334-1339
12. Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R 1972 Primary structure of ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc Natl Acad Sci USA 69:278-282
13. Clayton RN, Catt KJ 1981 Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocr Rev 2:186-209
14. Hazum E, Conn PM 1988 Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev 9:379-386
15. Conn PM, Janovick JA, Stanislaus D, Kuphal D, Jennes L 1995 Molecular and cellular bases of gonadotropin-releasing hormone action in the pituitary and central nervous system. Vitam Horm 50:151-214
16. Huckle WR, Conn PM 1988 Molecular mechanism of gonadotropin releasing hormone action. II. The effector system. Endocr Rev 9:387-395
17. Naor Z 1990 Signal transduction mechanisms of Ca2+ mobilizing hormones: the case of gonadotropin-releasing hormone. Endocr Rev 11:326-353
18. Stojilkovic SS, Reinhart J, Catt KJ 1994 Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr Rev 15:462-499
19. Stojilkovic SS, Catt KJ 1995 Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. J Neuroendocrinol 7:739-757
20. Stojilkovic SS, Catt KJ 1995 Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res 50:161-205
21. Karten MJ, Rivier JE 1986 Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonist and antagonists: rationale and perspective. Endocr Rev 7:44-66
22. Sherwood N, Eiden L, Brownstein M, Spiess J, Rivier J, Vale W 1983 Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci USA 80:2794-2798
23. King JA, Millar RP 1995 Evolutionary aspects of gonadotropin-releasing-hormone and its receptor. Cell Mol Neurobiol 15:5-23
24. Sealfon SC, Millar RP 1995 Functional domains of the gonadotropin-releasing hormone receptor. Cell Mol Neurobiol 15:25-42
25. Windle JJ, Weiner RI, Mellon PL 1990 Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 4:597-603
26. Sealfon SC, Gillo B, Mundamattom S, Mellon PL, Windle JJ, Landau E, Roberts JL 1990 Gonadotropin-releasing hormone receptor expression in Xenopus oocytes. Mol Endocrinol 4:119-124
27. Tsutsumi M, Zhou W, Millar RP, Mellon PL, Roberts JL, Flanagan CA, Dong K, Gillo B, Sealfon SC 1992 Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol 6:1163-1169
28. Reinhart J, Mertz LM, Catt KJ 1992 Molecular cloning and expression of cDNA encoding the murine gonadotropin-releasing hormone receptor. J Biol Chem 267:21281-21284
29. Perrin MH, Bilezikjian LM, Hoeger C, Donaldson CJ, Rivier J, Haas Y, Vale WW 1993 Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line. Biochem Biophys Res Commun 191:1139-1144
30. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD 1992 Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 189:289-295
31. Chi L, Zhou W, Prikhozhan A, Flanagan C, Davidson JS, Golembo M, Illing N, Millar RP, Sealfon SC 1993 Cloning and characterization of the human GnRH receptor. Mol Cell Endocrinol 91:R1-R6
32. Eidne KA, Sellar RE, Couper G, Anderson L, Taylor PL 1992 Molecular cloning and characterisation of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor. Mol Cell Endocrinol 90:R5-R9
33. Kaiser UB, Zhao D, Cardona GR, Chin WW 1992 Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun 189:1645-1652
34. Brooks J, Taylor PL, Saunders PT, Eidne KA, Struthers WJ, McNeilly AS 1993 Cloning and sequencing of the sheep pituitary gonadotropin-releasing hormone receptor and changes in expression of its mRNA during the estrous cycle. Mol Cell Endocrinol 94:R23-R27
35. Illing N, Jacobs GF, Becker II, Flanagan CA, Davidson JS, Eales A, Zhou W, Sealfon SC, Millar RP 1993 Comparative sequence analysis and functional characterization of the cloned sheep gonadotropin-releasing hormone receptor reveal differences in primary structure and ligand specificity among mammalian receptors. Biochem Biophys Res Commun 196:745-751
36. Kakar SS, Rahe CH, Neill JD 1993 Molecular cloning, sequencing, and characterizing the bovine receptor for gonadotropin releasing hormone (GnRH). Domest Anim Endocrinol 10:335-342
37. Weesner GD, Matteri RL 1994 Rapid communication: nucleotide sequence of luteinizing hormone-releasing hormone (LHRH) receptor cDNA in the pig pituitary. J Anim Sci 72:1911
38. Tensen C, Okuzawa K, Blomenroehr M, Rebers F, Leurs R, Bogerd J, Schulz R, Goos H 1997 Distinct efficacies for two endogenous ligands on a single cognate gonadoliberin receptor. Eur J Biochem 243:134-140
39. Ballesteros JA, Weinstein H 1995 Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366-428
40. Kakar SS, Grizzle WE, Neill JD 1994 The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 106:145-149
41. Moumni M, Kottler ML, Counis R 1994 Nucleotide sequence analysis of mRNAs predicts that rat pituitary and gonadal gonadotropin-releasing hormone receptor proteins have identical primary structure. Biochem Biophys Res Commun 200:1359-1366
42. Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S 1992 A family of metabotropic glutamate receptors. Neuron 8:169-179
43. Pin JP, Duvoisin R 1995 The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26
44. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski Jr LF, Lodish HF, Goldring SR 1991 Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254:1022-1024
45. Ishihara T, Nakamura S, Kaziro Y, Takahashi T, Takahashi K, Nagata S 1991 Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J 10:1635-1641
46. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts Jr J, Kronenberg HM, Segre GV 1992 Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736
47. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971
48. Juppner H 1994 Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors. Curr Opin Nephrol Hypertens 3:371-378
49. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC 1992 Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11:1-20
50. Strader CD, Fong TM, Graziano MP, Tota MR 1995 The family of G-protein-coupled receptors. FASEB J 9:745-754
51. Zhou W, Flanagan C, Ballesteros JA, Konvicka K, Davidson JS, Weinstein H, Millar RP, Sealfon SC 1994 A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol 45:165-170
52. Perrin MH, Haas Y, Porter J, Rivier J, Vale W 1989 The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate-binding protein: differential effects of guanyl nucleotides on agonist and antagonist binding. Endocrinology 124:798-804
53. Limor R, Schvartz I, Hazum E, Ayalon D, Naor Z 1989 Effect of guanine nucleotides on stimulus secretion coupling mechanism in permeabilized pituitary cells: relationship to gonadotropin releasing hormone action. Biochem Biophys Res Commun 159:209-215
54. Hsieh K-P, Martin TFJ 1992 Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol 6:1673-1681
55. Anderson L, Hoyland J, Mason WT, Eidne KA 1992 Characterization of the gonadotrophin-releasing hormone in single alphaT3-1 pituitary gonadotroph cells. Mol Cell Endocrinol 86:167-175
56. Pardo L, Ballesteros JA, Osman R, Weinstein H 1992 On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc Natl Acad Sci USA 89:4009-4012
57. Grigorieff N, Ceska TA, Downing KH, Baldwin JM, Henderson R 1996 Electron-crystallographic refinement of the structure of bacteriorhodopsin. J Mol Biol 259:393-421
58. Schertler GF, Villa C, Henderson R 1993 Projection structure of rhodopsin. Nature 362:770-772
59. Schertler GFX, Hargrave PA 1995 Projection structure of frog rhodopsin in two crystal forms. Proc Natl Acad Sci USA 92:11578-11582
60. Arora KK, Sakai A, Catt KJ 1995 Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J Biol Chem 270:22820-22825
61. Hargrave PA 1977 The amino-terminus tryptic peptide of bovine rhodopsin. A glycopeptide containing two sites of oligosaccaride attachment. Biochim Biophys Acta 492:83-94
62. Rands E, Candelore MR, Cheung AH, Hill WS, Strader CD, Dixon RAF 1990 Mutational analysis of β-adrenergic receptor glycosylation. J Biol Chem 265:10759-10764
63. Fishburn CS, Elazar Z, Fuchs S 1995 Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor. J Biol Chem 270:29819-29824
64. Hazum E 1982 GnRH-receptor of rat pituitary is a glycoprotein: differential effect of neuraminidase and lectins on agonists and antagonists binding. Mol Cell Endocrinol 26:217-222
65. Schvartz I, Hazum E 1985 Tunicamycin and neuraminidase effects of luteinizing hormone (LH)-releasing hormone binding and LH release from rat pituitary cells in culture. Endocrinology 116:2341-2346
66. Keinan D, Hazum E 1985 Mapping of gonadotropin-releasing hormone receptor binding site. Biochemistry 17:7728-7732
67. Davidson JS, Flanagan CA, Zhou W, Becker II, Elario R, Emeran W, Sealfon SC, Millar RP 1995 Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding. Mol Cell Endocrinol 107:241-245
68. Davidson JS, Flanagan CA, Davies PD, Hapgood J, Myburgh D, Elario R, Millar RP, Forrest-Owen W, McArdle CA 1996 Incorporation of an additional glycosylation site enhances expression of functional human gonadotropin-releasing hormone receptor. Endocrine 4:207-212
69. McArdle CA, Forrest-Owen W, Willars G, Davidson J, Poch A, Kratzmeier M 1995 Desensitization of gonadotropin-releasing hormone action in the gonadotrope-derived alpha T3-1 cell line. Endocrinology 136:4864-4871
70. Davidson JS, Wakefield IK, Millar RP 1994 Absence of rapid desensitization of the mouse gonadotropin-releasing hormone receptor. Biochem J 300:299-302
71. Anderson L, McGregor A, Cook JV, Chilvers E, Eidne KA 1995 Rapid desensitization of GnRH-stimulated intracellular signalling events in alpha T3-1 and HEK-293 cells expressing the GnRH receptor. Endocrinology 136:5228-5231
72. Dixon RA, Sigal LS, Candelore MR, Register RB, Rands E, Strader CD 1987 Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J 6:3269-3275
73. Karnik SS, Sakmann JP, Chen HB, Khorana HG 1988 Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc Natl Acad Sci USA 85:8459-8463
74. Fraser CM 1989 Site-directed mutagenesis of β-adrenergic receptors: identification of conserved cysteine residues that independently affect ligand binding and receptor activation. J Biol Chem 264:9266-9270
75. Savarese TM, Wang CD, Fraser CM 1992 Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. J Biol Chem 267:11439-11448
76. Perlman JH, Wang W, Nussenzveig DR, Gershengorn MC 1995 A disulfide bond between conserved extracellular cysteines in the thyrotropin-releasing hormone receptor is critical for binding. J Biol Chem 270:24682-24685
77. Fan NC, Jeung EB, Peng C, Olofsson JI, Krisinger J, Leung PC 1994 The human gonadotropin-releasing hormone (GnRH) receptor gene: cloning, genomic organization and chromosomal assignment. Mol Cell Endocrinol 103:R1-R6
78. Kakar SS, Neill JD 1995 The human gonadotropin-releasing hormone receptor gene (GnRHR) maps to chromosome band 4q13. Cytogenet Cell Genet 70:211-214
79. Kaiser UB, Dushkin H, Altherr MR, Beier DR, Chin WW 1994 Chromosomal localization of the gonadotropin-releasing hormone receptor gene to human chromosome 4q13.1-q21.1 and mouse chromosome 5. Genomics 20:506-508
80. Kottler ML, Lorenzo F, Bergametti F, Commercon P, Souchier C, Counis R 1995 Subregional mapping of the human gonadotropin-releasing hormone receptor (GnRH-R) gene to 4q between the markers D4S392 and D4S409. Hum Genet 96:477-480
81. Morrison N, Sellar RE, Boyd E, Eidne KA, Connor JM 1994 Assignment of the gene encoding the human gonadotropin-releasing hormone receptor to 4q13.2-13.3 by fluorescence in situ hybridization. Hum Genet 93:714-715
82. Leung PC, Squire J, Peng C, Fan N, Hayden MR, Olofsson JI 1995 Mapping of the gonadotropin-releasing hormone (GnRH) receptor gene to human chromosome 4q21.2 by fluorescence in situ hybridization. Mamm Genome 6:309-310
83. Montgomery GW, Penty JM, Lord EA, Brooks J, McNeilly AS 1995 The gonadotrophin-releasing hormone receptor maps to sheep chromosome 6 outside of the region of the FecB locus. Mamm Genome 6:436-438
84. Brosius J 1991 Retroposons-seeds of evolution. Science 251:753
85. Zhou W, Sealfon SC 1994 Structure of the mouse gonadotropin-releasing hormone receptor gene: variant transcripts generated by alternative processing. DNA Cell Biol 13:605-614
86. Fan NC, Peng C, Krisinger J, Leung PC 1995 The human gonadotropin-releasing hormone receptor gene: complete structure including multiple promoters, transcription initiation sites, and polyadenylation signals. Mol Cell Endocrinol 107:R1-R8
87. Albarracin CT, Kaiser UB, Chin WW 1994 Isolation and characterization of the 5′-flanking region of the mouse gonadotropin-releasing hormone receptor gene. Endocrinology 135:2300-2306
88. Rivier J, Gicrasch L, Rizo J, Koerhe SC, Hagler A, Porter J, Corrigan A, Vale W, Rivier C 1992 Probing the GnRH receptor with linear and cyclic analogs. In: Yanaihara N (ed) Peptide Chemistry. Escom., Leiden, pp 313-317
89. Rivier J 1993 Novel antagonists of GnRH: a compendium of their physicochemical properties activities relative potencies, efficacy in humans. In: Lunenfeld B, Insler V (eds) GnRH Analogues: The State of the Art. Parthenon Publishing Group, New York, pp 13-26
90. Rivier JE, Jiang G, Porter J, Hoeger CA, Craig AG, Corrigan A, Vale W, Rivier CL 1995 Gonadotropin-releasing hormone antagonists: novel members of the azaline B family. J Med Chem 38: 2649-2662
91. Janecka A, Janecka T, Bowers C, Folkers K 1994 The structural features of effective antagonists of luteinizing-hormone-releasing hormone. Amino Acids 6:111-130
92. Millar RP, King JA 1984 Structure-activity relations of LH-RH in birds. J Exp Zool 232:425-430
93. Millar RP, King JA 1987 Structural and functional evolution of gonadotropin-releasing hormone. Int Rev Cytol 106:149-182
94. King JA, Millar RP 1987 Phylogenetic diversity of LHRH. In: Vickery BH, Nestor JJ (eds) LHRH and Its Analogs Contraceptive and Therapeutic Applications. MTP Press Ltd, Lancaster, U.K., pp 53-73
95. Millar RP, King JA 1988 Evolution of gonadotropin-releasing hormone: multiple usage of a peptide. News Physiol Sci 3:49-53
96. King JA, Millar RP 1990 Genealogy of the GnRH family. In: Epple A, Scanes CG, Stetson MH (eds) Progress in Comparative Endocrinology. Wiley-Liss, New York, pp 54-59
97. King JA, Millar RP 1992 Evolution of gonadotropin-releasing hormone. Trends Endocrinol Metab 3:339-346
98. Millar RP, King J A 1994 Plasticity, conservation in gonadotropin-releasing hormone structure, function. In: Davey KG, Peter RE, Tobe SS (eds) Perspectives in Comparative Endocrinology. National Research Council of Canada, pp 129-136
99. King JA, Millar RP 1995 Evolutionary aspects of gonadotropin-releasing hormone and its receptor. Cell Mol Neurobiol 15:5-23
100. Hahn DW, McGuire JL, Vale W, Rivier J 1984 Biological assays utilized to characterize LHRH, its analogs. In: Vickery BN, Nestor JJ, Hafez ESE (eds) LHRH, Its Analogs. MTP Press, Lancaster, p 49
101. Millar RP, Davidson J, Flanagan C, Wakefield I 1995 Ligand binding and second-messenger assays for cloned Gq/G11-coupled neuropeptide receptors: the GnRH receptor. Methods Neurosci 25:145-162
102. Kenakin T 1995 Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 16:188-192
103. Sherwood N 1987 The GnRH family of peptides. Trends Neurosci 10:129-132
104. Sherwood NM, Lovejoy DA 1989 The origin of the mammalian form of GnRH in primitive fishes. Fish Physiol Biochem 7:85-93
105. Muske LE 1993 Evolution of gonadotropin-releasing hormone (GnRH) neuronal systems. Brain Behav Evol 42:215-230
106. King JA, Millar RP 1979 Heterogeneity of vertebrate luteinizing hormone-releasing hormone. Science 206:67-69
107. King JA, Millar RP 1982 Structure of chicken hypothalamic LHRH I. structural determination on partially purified material. J Biol Chem 257:10722-10728
108. King JA, Millar RP 1982 Structure of chicken hypothalamic LHRH II. isolation and characterization. J Biol Chem 257:10729-10732
109. Miyamoto K, Hasegawa Y, Igarashi M, Chino N, Sakakibara S, Kangawa K, Matsuo H 1983 Evidence that chicken hypothalamic luteinizing hormone-releasing hormone is (Gln8)-LH-RH. Life Sci 32:1341-1347
110. Miyamato K, Hasegawa Y, Nomura M, Igarashi M, Kangawa K, Matsuo H 1984 Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hoermones in avian species. Proc Natl Acad Sci USA 81: 3874-3878
111. Sherwood NM, Sower SA, Marshak DR, Fraser BA, Brownstein MJ 1986 Primary structure of gonadotropin-releasing hormone from lamprey brain. J Biol Chem 261:4812-4819
112. Sower SA, Chiang YC, Lovas S, Conlon JM 1993 Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain. Endocrinology 132:1125-1131
113. Ngamvongchon S, Lovejoy DA, Fischer WH, Craig AG, Nahornisk CS, Peter RE, Rivier JE, Sherwood NM 1992 Primary structure of two forms of gonadotropin-releasing hormone, one distinct and one conserved, from catfish brain. Mol Cell Neurosci 3:17-22
114. Lovejoy DA, Fischer WH, Ngamvongchon S, Craig AG, Nahorniak CS, Peter RE, Rivier JE, Sherwood NM 1992 Distinct sequence of gonadotropin-releasing hormone (GnRH) in dogfish brain provides insight into GnRH evolution. Proc Natl Acad Sci USA 89:6373-6377
115. Powell JF, Zohar Y, Elizur A, Park M, Fischer WH, Craig AG, Rivier JE, Lovejoy DA, Sherwood NM 1994 Three forms of gonadotropin-releasing hormone characterized from brains of one species. Proc Natl Acad Sci USA 91:12081-12085
116. Sherwood NM, The origin and evolution of gonadotropin-releasing hormone. Program of the 77th Annual Meeting of The Endocrine Society, Washington, DC, 1995, p 21
117. Jones SW 1987 Chicken II luteinizing hormone-releasing hormone inhibits the M-current of bullfrog sympathetic neurons. Neurosci Lett 80:180-184
118. Millar R, Illing N, Hapgood J, Rumbad E, Flanagan C, Davidson J, Balckman B, Sun Y, Sealfon SC, Weinstein H, Konvicka K, Guarnieri F, King J Co-ordinated structural evolution of GnRHs and their receptors-insights from comparative studies. Proceedings of the Asian Oceanic Society for Comparative Endocrinology, Sydney, 1996, pp 13-17
119. Millar RP, King JA 1983 Synthesis, luteinizing hormone-releasing activity, and receptor binding of chicken hypothalamic luteinizing hormone-releasing hormone. Endocrinology 113:1364-1369
120. Millar RP, Milton RC, Follett BK, King JA 1986 Receptor binding and gonadotropin-releasing activity of a novel chicken gonadotropin-releasing hormone ([His5, Trp7, Tyr8]GnRH) and a D-Arg6 analog. Endocrinology 119:224-231
121. Millar RP, Flanagan CA, Milton RCL, King JA 1989 Chimeric analogues of vertebrate gonadotropin-releasing hormones comprising substitutions of the variant amino acids in positions 5,7, and 8. J Biol Chem 264:21007-21013
122. Folkers K, Bowers CY, Tang PF, Kubota M 1986 Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 83:1070-1074
123. Lovejoy DA, Corrigan AZ, Nahorniak CS, Perrin MH, Porter J, Kaiser R, Miller C, Pantoja D, Craig AG, Peter RE, Vale WW, Rivier JE, Sherwood NM 1995 Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues. Regul Pept 60:99-115
124. Habibi HR, Peter RE, Nahorniak CS, DeMilton RC, Millar RP 1992 Activity of vertebrate gonadotropin-releasing hormones and analogs with variant amino acid residues in positions 5, 7 and 8 in the goldfish pituitary. Regul Pept 37:271-284
125. Licht P, Porter D, Millar RP 1987 Specificity of amphibian and reptilian pituitaries for various forms of gonadotropin-releasing hormones in vitro. Gen Comp Endocrinol 66:248-255
126. Jacobs GFM, Flanagan CA, Roeske RW, Millar RP 1995 Agonist activity of mammalin GnRH antagonists in chicken gondotropes reflect differences in vertebrate GnRH receptors. Mol Cell Endocrinol 108:107-113
127. Murthy CK, Nahorniak CS, Rivier JE, Peter RE 1993 In vitro characterization of gonadotropin-releasing hormone antagonists in goldfish, Carassius auratus. Endocrinology 133:1633-1644
128. Wormald PJ, Eidne KA, Millar RP 1985 Gonadotropin-releasing hormone receptors in human pituitary: ligand structural requirements, molecular size, and cationic effects. J Clin Endocrinol Metab 61:1190-1194
129. Sandow J, Konig W, Geiger R, Uhman R, Von Rechenberg W 1978 Structure-activity relationships in the LH-KH molecule. In: Crighton DB, Haynes NB, Foxcroft GR, Lamming GE (eds) Control of Ovulation. Buttersworths, London, pp 47-70
130. Fujino M, Kobayashi S, Obayashi M, Fukuda T, Shinagawa S 1972 Synthesis and biological activities of analogs of luteinizing hormone releasing hormone (LH-RH). Biochem Biophys Res Commun 49:698-705
131. Okada T, Kitamura K, Baba Y, Arimura A, Schally AV 1973 Luteinizing hormone-releasing hormone analogs lacking N-terminal pGLU ring structure. Biochem Biophys Res Commun 53:1180-1186
132. Coy DH, Coy EJ, Schally AV 1973 Effect of simple amino acid replacements on the biological activity of luteinizing hormone-releasing hormone. J Med Chem 16:1140-1143
133. Hirotsu Y, Coy DH, Coy EJ, Schally AV 1974 Stereoisomers of luteinizing hormone-releasing hormone. Biochem Biophys Res Commun 59:277-282
134. Coy DH, Coy EJ, Schally AV 1975 Structure-activity relationship of LH, FSH releasing hormone. In: Marks N, Rodnight R (eds) Research Methods in Neurochemistry. Plenum, New York, pp 393-404
135. Yanaihara N, Tsuji K, Yanihara C, Hashimoto T, Kaneko T, Oka H, Aminura A, Schally AV 1973 Synthesis and biological activities of analogs of luteinizing hormone-releasing hormone (LH-RH) substituted in position 1 or 2. Biochem Biophys Res Commun 51:165-173
136. Grant GF, Vale W 1994 Hypothalamic control of anterior pituitary hormone secretion-characterized hypothalamic-hypophysiotropic peptides. In: James VHT, Mastini L (eds) Current Topics in Experimental Endocrinology. Academic Press, New York, vol 2:38-62
137. Monahan MW, Amoss MS, Anderson HA, Vale W 1973 Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties. Biochemistry 12: 4616-4620
138. 2.61(98) in agonist completing with the human gonadotropin-releasing hormone receptor. Soc Neurosci Abstr 25: 1302
139. Rivier J, Monahan M, Vale W, Grant G, Amoss M, Blackwell R, Guillemin R, Burgus R 1972 Solid-phase peptide synthesis on a benzhydrylamine resin of LRF (luteinizing hormone releasing factor) and analogues, including antagonists. Chimia 26:300-303
140. Coy DH, Coy EJ, Hirotsu Y, Schally AV 1974 Synthesis and biological properties of (2-L-beta-(pyrazolyl-3)alanine)-luteinizing hormone-releasing hormone. J Med Chem 17:140-142
141. Vale W, Grant G, Rivier J, Monahan M, Amoss M, Blackwell R, Burgus R, Guillemin R 1972 Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor. Science 176:933-934
142. Zhou W, Rodic V, Kitanovic S, Flanagan CA, Chi L, Weinstein H, Maayani S, Millar RP, Sealfon SC 1995 A locus of the gonadotropin-releasing hormone receptor that differentiates agonist and antagonist binding sites. J Biol Chem 270:18853-18857
143. Yanaihara N, Hashimoto T, Yanaihara C, Tsuji K, Kenmochi Y, Ashizawa F, Kaneko T, Oka H, Arimura A, Schally AV 1973 Synthesis and biological evaluation of analogs of luteinizing hormone-releasing hormone (LH-RH). Biochem Biophys Res Commun 52:64-73
144. Coy DH, Coy EJ, Schally AV, Vilchez-Martinez JA, Debeljuk L, Carter WH, Arimura A 1974 Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone. Biochemistry 13:323-326
145. Vilchez-Martinez LA, Coy DH, Coy EJ, Schally AV, Arimura A 1975 Anti-luteinizing hormone (LH)-releasing activity of several analogues of LH-releasing hormone. Fertil Steril 26:554-559
146. Haviv F, Fitzpatrick TD, Swenson RE, Nichols CJ, Mort NA, Bush EN, Diaz G, Bammert G, Nguyen A, Rhutasel NS, Nellons HN, Hoffman DJ, Johnson ES, Greer J 1993 Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists. J Med Chem 36:363-369
147. Konig W, Sandow J, Geiger R 1975 Peptides: chemistry structure and biology. In: Walker R, Meienhofer J (eds) Proceedings of the 4th American Peptide Symposium. Ann Arbor Publishers, Ann Arbor, MI, pp 883-888
148. Miller BT, Collins TJ, Nagle GT, Kurosky A 1992 The occurrence of O-acylation during biotinylation of gonadotropin-releasing hormone and analogs. Evidence for a reactive serine. J Biol Chem 267:5060-5069
149. d) luteinizing hormone-releasing hormone: a novel peptide in mammalian and frog hypothalamus. Neurochem Int 2:221-235
150. Fujino M, Kobayashi S, Obayashi M, Shinagawa S, Fukuda T 1972 Structure-activity relationships in the C-terminal part of luteinizing hormone releasing hormone(LH-RH). Biochem Biophys Res Commun 49:863-869
151. Coy DH, Vilchez-Martinez JA, Coy EJ, Nishi N, Arimura A, Schally AV 1975 Polyfluoroalkylamine derivatives of luteinizing hormone-releasing hormone. Biochemistry 14:1848-1851
152. 102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide. J Biol Chem 271:15510-15514
153. Coy DH, Coy EJ, Schally AV 1973 Analogs of luteinizing hormone-releasing hormone containing derivatives of phenylalanine in place of tyrosine. J Med Chem 16:827-829
154. Coy DH, Vilchez-Martinez JA, Coy EJ, Arimura A, Schally AV 1973 A peptide inhibitor of luteinizing hormone-releasing hormone (LH-RH). J Clin Endocrinol Metab 37:331-333
155. Haviv F, Fitzpatrick TD, Nichols CJ, Swenson RE, Mort NA, Bush EN, Diaz G, Nguyen AT, Holst MR, Cybulski VA, Leal JA, Bammert G, Rhutasel NS, Dodge PW, Johnson ES, Cannon JB, Knittle J, Greer J 1993 The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists. J Med Chem 36:928-933
156. Ling N, Vale W 1975 Analogs of luteinizing hormone releasing factor (LRF): synthesis and biological activity of [N*-Me)Leu7]LRF and [D-Ala6,N*-Me)-Leu7]LRF. Biochem Biophys Res Commun 63:801-806
157. Chang JK, Sievertsson H, Currie BL, Bogentoft C, Folkers K, Bowers CY 1972 Synthesis of the luteinizing-releasing hormone of the hypothalamus and the 8-lysine analog. J Med Chem 15:623-627
158. Yanaihara N, Yanaihara C, Hashimoto T, Kenmochi Y, Kaneko T, Oka H, Saito S, Schally AV, Arimura A 1972 Syntheses and LH-and FSH-RH activities of LH-RH analogs substituted at position 8. Biochem Biophys Res Commun 49:1280-1291
159. Yabe Y, Kitamura K, Miura C, Baba Y 1974 Analogues of luteinizing hormone-releasing hormone with modification in position 8. Chem Pharm Bull (Tokyo) 22:2557-2564
160. Shinitzky M, Hazum E, Fridkin M 1976 Structure-activity relationships of luliberin substituted at position 8. Biochim Biophys Acta 453:553-557
161. Shinitzky M, Fridkin M 1976 Structural features of luliberin (luteinising hormone-releasing factor) inferred from fluorescence measurements. Biochim Biophys Acta 434:137-143
162. Milton RCdL, King JA, Badminton MN, Tobler CJ, Lindsey GG, Fridkin M, Millar RP 1983 Comparative structure-activity studies on mammalian Arg8 LH-RH and Gln8 LH-RH by fluorimetric titration. Biochem Biophys Res Commun 111:1082-1088
163. Hazum E 1987 Binding properties of solubilized gonadotropin-releasing hormone receptor: role of carboxylic groups. Biochemistry 26:7011-7014
164. Keinan D, Hazum E 1985 Mapping the gonadotropin-releasing hormone receptor binding site. Biochemistry 24:7728-7732
165. Momany FA 1976 Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. 2. Tetrapeptide and decapeptide analogues. J Am Chem Soc 98:2996-3000
166. Momany FA 1976 Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. 1. Native decapeptide. J Am Chem Soc 98:2990-2996
167. Gupta HM, Talwar GP, Salunke DM 1993 A novel computer modeling approach to the structures of small bioactive peptides: the structure of gonadotropin releasing hormone. Proteins Struct Funct Genet 16:48-56
168. Struthers RS, Rivier J, Hagler AT 1985 Molecular dynamics and minimum energy conformations of GnRH and analogs. A methodology for computer-aided drug design. Ann NY Acad Sci 439: 81-96
169. Janecka A, Ljungqvist A, Bowers C, Folkers K 1991 Superiority of an antagonist of the luteinizing hormone releasing hormone with emphasis on arginine in position 8, named Argtide. Biochem Biophys Res Commun 180:374-379
170. Nikolics K, Szonyi E, Ramachandran J 1989 Photoaffinity labeling of pituitary GnRH receptors: significance of the position of the photolabel on the ligand. Biochemistry 27:1425-1432
171. Rivier J, Kupryszewski G, Varga J, Porter J, Rivier C, Perrin M, Hagler A, Struthers S, Corrigan A, Vale W 1988 Design of potent cyclic gonadotropin releasing hormone antagonists. J Med Chem 31:677-682
172. Hruby VJ (ed) 1985 Conformation in biology, drug design. In: The Peptides: Analysis Synthesis Biology. Academic Press, Orlando, FL, vol 7
173. Nikiforovich GV 1994 Computational molecular modeling in peptide drug design. Int J Pept Protein Res 44:513-531
174. Struthers RS, Tanaka G, Koerber SC, Solmajer T, Baniak EL 1990 Design of biologically active, conformationally constrained GnRH antagonists. Proteins Struct Funct Genet 8:295-304
175. Guarnieri F, Weinstein H 1996 Conformational memories and the exploration of biologically relevant peptide conformations: an illustration for the gonadotropin-releasing hormone. J Am Chem Soc 118:5580-5589
176. Momany FA 1978 Conformational analysis of the molecule luteinizing hormone-releasing hormone. 3. Analogue inhibitors and antagonists. J Med Chem 21:63-68
177. Zimmerman SS 1985 Theoretical methods in the analysis of peptide conformation. Conformation in biology, drug design. In: Hruby (ed) The Peptides. Academic Press, New York, vol 7:165-212
178. Bienstock RJ, Rizo J, Koerber SC, Rivier JE, Hagler AT, Gierasch LM 1993 Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics. J Med Chem 36:3265-3273
179. Paul PK, Dauber-Osguthorpe P, Campbell MM, Osguthorpe DJ 1989 A novel beta-turn location in an LHRH antagonist: a combined Conformational search and molecular dynamics study. Biochem Biophys Res Commun 165:1051-1058
180. Marshall GR 1992 Three-dimensional structure of peptide-protein complexes: implications for recognition. Curr Opin Struct Biol 2:904-919
181. Sprecher RF, Momany FA 1979 On the conformation of luteinizing hormone-releasing hormone, nuclear Overhauser observations. Biochem Biophys Res Commun 87:72-77
182. Hagler AT 1985 Theoretical simulation of conformation energetics and dynamics of peptides. Conformation in biology and drug design. In: Hruby VJ (ed) The Peptides. Academic Press, New York, vol:213-299
183. Guarnieri F, Wilson SR 1995 Conformational memories and a simulated annealing program that learns. Application to LTB4. J Comput Chem 16:648-653
184. Metropolis N, Rosenbluth AW, Rosenbluth MN, Teller AH, Teller E 1953 Equation of state calculations by fast computing machines. J Chem Phys 21:1087-1092
185. Kirkpatrick S, Gelatt CD, Vecchi MP 1983 Simulated annealing. Science 220:671
186. Baniak E, Rivier JE, Struthers RS, Hagler AT, Gierasch LM 1987 Nuclear magnetic resonance analysis and conformational characterization of a cyclic decapeptide antagonist of gonadotropin-releasing hormone. Biochemistry 26:2642-2656
187. Flanagan CA, Becker II, Davidson JS, Wakefield IK, Zhou W, Sealfon SC, Millar RP 1994 Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone. J Biol Chem 269:22636-22641
188. Ho BY, Karschin A, Branchek T, Davidson N, Lester HA 1992 The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1A receptor: a site-directed mutation study. FEBS Lett 312:259-262
189. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179
190. Wang C-D, Gallaher TK, Shih JC 1993 Site directed mutagenesis of the serotonin 5-hydroxytryptamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol Pharmacol 43:931-940
191. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS, Dixon RAF 1988 Conserved aspartate residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J Biol Chem 263:10267-10271
192. Mansour A, Meng F, Meador WJ, Taylor LP, Civelli O, Akil H 1992 Site-directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol 227:205-214
193. Gantz I, DelValle J, Wang L, Tashiro T, Munzert G, Guo YJ, Konda Y, Yamada T 1992 Molecular basis for the interaction of histamine with the histamine H2 receptor. J Biol Chem 267:20840-20843
194. Fraser CM, Wang CD, Robinson DA, Gocayne JD, Venter JC 1989 Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol Pharmacol 36:840-847
195. Perlman JH, Laakkonen L, Osman R, Gershengorn MC 1994 A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. J Biol Chem 269:23383-23386
196. 3.36(159) provides a second interaction site for the protonated amine of serotonin but not of LSD or bufotenin. J Biol Chem 271:14672-14675
197. Rodic V, Flanagan C, Millar R, Konvicka K, Weinstein H, Sealfon SC 1996. Role of Asp2.61(198) in agonist complexing with the human gonadotropin-releasing hormone receptor. Soc Neurosci Abstr 22:1302
198. Cook JV, Faccenda E, Anderson L, Couper GG, Eidne KA, Taylor PL 1993 Effects of Asn87 and Asp318 mutations on ligand binding and signal transduction in the rat GnRH receptor. J Endocrinol 139:R1-R4
199. Awara WM, Guo C-H, Conn PM 1996 Effects of Asn318 and Asp87Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinology 137:655-662
200. 2A receptor. J Biol Chem 370:16683-16688
201. Jagerschmidt A, Guillaume N, Goudreau N, Maigret B, Roques BP 1995 Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol Pharmacol 48:783-789
202. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ 1991 Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 60:653-688
203. Chi L, Davidson JS, Zhou W, Millar RP, Sealfon SC, Mutations of the second intracellular loop domain of the GnRH receptor. Program of the 76th Annual Meeting of The Endocrine Society, 1994, Anaheim, CA (Abstract 159)
204. Ovchinnikov YA, Abdulaev NG, Bogachuk AS 1988 Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Lett 230:1-5
205. 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem 264:7564-7569
206. Ng GY, George SR, Zastawny RL, Caron M, Bouvier M, Dennis M, O'Dowd BF 1993 Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry 32:11727-11733
207. Zhu H, Wang H, Ascoli M 1995 The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues. Mol Endocrinol 9:141-150
208. Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ 1987 Regulation of transmembrane signaling by receptor phosphorylation. Cell 48: 913-922
209. Leeb-Lundberg LMF, Cotecchia S, DeBlasi A, Caron MG, Lefkowitz RJ 1987 Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of α1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MR-2 smooth muscle cells. J Biol Chem 262:3098-3105
210. Nussenzveig DR, Heinflink M, Gershengorn MC 1993 Agonist-stimulated internalization of the thyrotropin-releasing hormone receptor is dependent on two domains in the receptor carboxyl terminus. J Biol Chem 268:2389-2392
211. Benya RV, Fathi Z, Battey JF, Jensen RT 1993 Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. J Biol Chem 268:20285-20290
212. Hunyady L, Bor M, Balla T, Catt KJ 1994 Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem 269: 31378-31382
213. Thomas WG, Baker KM, Motel TJ, Thekkumkara TJ 1995 Angiotensin II receptor endocytosis involves two distinct regions of the cytoplasmic tail. A role for residues on the hydrophobic face of a putative amphipathic helix. J Biol Chem 270:22153-22159
214. Sanchez-Yague J, Rodriguez MC, Segaloff DL, Ascoli M 1992 Truncation of the cytoplasmic tail of the lutropin/choriogonadotropin receptor prevents agonist-induced uncoupling. J Biol Chem 267:7217-7220
215. Zhu X, Gudermann T, Birnbaumer M, Birnbaumer L 1993 A luteinizing hormone receptor with a severely truncated cytoplasmic tail (LHR-ct628) desensitizes to the same degree as the full-length receptor. J Biol Chem 268:1723-1728
216. Sasakawa N, Sharif M, Hanley MR 1994 Attenuation of agonist-induced desensitization of the rat substance P receptor by progressive truncation of the C-terminus. FEBS Lett 347:181-184
217. Alblas J, van Etten I, Khanum A, Moolenaar WH 1995 C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. Role of receptor phosphorylation in signal attenuation. J Biol Chem 270:8944-8951
218. Lattion AL, Diviani D, Cotecchia S 1994 Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor. J Biol Chem 269:22887-22893
219. Strader CD, Sigal IS, Blake AD, Cheung AH, Register RB, Rands E, Zemcik BA, Canderlore MR, Dixon RAF 1987 The carboxyl terminus of the hamster beta-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration. Cell 49: 855-863
220. Hipkin RW, Liu XB, Ascoli M 1995 Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem 270:26683-26689
221. Baldwin JM 1993 The probable arrangement of the helices in G protein-coupled receptors. EMBO J 12:1693-703
222. Lesk AM, Boswell DR 1992 Homology modelling: inferences from tables of aligned sequences. Curr Opin Struct Biol 2:242-247
223. Donnelly D, Johnson MS, Blundell TL, Saunders J 1989 An analysis of the periodicity of conserved residues in sequence alignments of G-protein coupled receptors. FEBS Lett 251:109-116
224. Eisenberg D, Weiss RM, Terwilliger TC 1984 The hydrophobic moment detects periodicity in protein hydrophobicity. Proc Natl Acad Sci USA 81:140-144
225. Williams KA, Deber CM 1991 Proline residues in transmembrane helices: structural or dynamic role? Biochemistry 30:8919-8923
226. Ballesteros JA, Weinstein H 1992 Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. Biophys J 62:107-109
227. Sankararamakrishnan R, Vishveshwara S 1992 Geometry of proline-containing alpha-helices in proteins. Int J Pept Protein Res 39:356-363
228. Liu J, Schoneberg T, Rhee M, Wess J 1995 Mutational analysis of the relative orientation of transmembrane helices I and VII in G protein-coupled receptors. J Biol Chem 270:19532-19539
229. Hwa J, Graham RM, Perex DM 1996 Chimeras of α1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization. J Biol Chem 271:7956-7964
230. Thirstrup K, Elling CE, Hjorth SA, Schwartz TW 1996 Construction of a high affinity zinc switch in the κ-opioid receptor. J Biol Chem 271:7875-7878
231. Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC 1996 Contribution of a helix 5 locus to selectivity of hallucinogenic and non-hallucingenic ligands for the human 5-HT2A and 5-HT2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. Mol Pharmacol 50:34-42
232. Bhogal N, Donnelly D, Findlay JB 1994 The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. J Biol Chem 269:27269-27274
233. Perlman JH, Thaw CN, Laakkonen L, Bowers CY, Osman R, Gershengorn MC 1994 Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J Biol Chem 269:1610-1613
234. Perlman JH, Nussenzveig DR, Osmasn R, Gershengorn MC 1992 Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. J Biol Chem 267: 24413-24417
235. Donnelly D, Findlay JB, Blundell TL 1994 The evolution and structure of aminergic G protein-coupled receptors. Receptors Channels 2:61-78
236. Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE 1991 Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 179:1232-1240
237. Kobilka BK, Dixon RAF, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-feng TL, Francke U, Caron MG, Lefkowitz RJ 1987 cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84:46-50
238. Nathans J, Hogness DS 1984 Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proc Natl Acad Sci USA 81:4851-4855
239. van Rhee AM, Jacobson KA 1996 Molecular architecture of G protein-coupled receptors. Drug Dev Res 37:1-38